IL-6 is not commonly available (it is neither cost-effective nor cost-saving), and procalcitonin is known to exhibit physiological elevations in the early postnatal period (it may sometimes lead to confusion regarding the prediction of early-onset neonatal sepsis), limiting its diagnostic utility. Here, IL6 is linked to Neonatal sepsis.